BSE filing, NSE: DHARTI. Summary written from the filing by ALFA Finder's alert engine.
Dharti Proteins Ltd: key numbers
- Share price
- ₹127.30
- Market cap
- ₹6.36 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.85 Cr
- Promoter holding
- 85.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dharti Proteins Ltd
All →Dharti Proteins Other Announcement
Dharti Proteins confirmed its registrar and share transfer agent change from System Support Services to Bigshare Services, effective November 6, 2026. Depository connectivity has shifted to Bigshare, a routine administrative update with no financial impact.
Dharti Proteins Bonus Issue
Dharti Proteins shareholders approved a bonus share issue to public holders for minimum public shareholding compliance. All votes polled were in favour, 100% of votes cast.
Dharti Proteins Bonus Issue
Dharti Proteins Limited issued an EOGM notice scheduled for November 06, 2026, to seek shareholder approval for a 1:1 bonus issue.
Dharti Proteins Financial Results
Dharti Proteins Ltd approved its audited standalone financial results for the quarter ended September 30, 2026, and recommended a 1:1 bonus issue of equity shares.
Dharti Proteins Bonus Issue
Dharti Proteins Limited approved a 1:1 bonus issue, capitalizing Rs.0.075 Crore from reserves. The record date is fixed for November 13, 2026.
- Value
- ₹0.07 Cr
Dharti Proteins Q2 FY27 Results: Net Profit ₹3.4 Cr
Dharti Proteins Ltd reported revenue from operations of ₹2.9 Cr and net profit of ₹3.4 Cr for Q2 FY27.
- Key figure
- Net profit ₹3.4 Cr
Other other announcement announcements
All →Kingfa Science & Technology (India) Other Announcement
Kingfa filed CARE Ratings' monitoring report on its Rs.500 crore preferential issue proceeds. Nil deviation from issue objects was reported for the quarter ended September 30, 2026.
Stallion India Fluorochemicals Other Announcement
Stallion India Fluorochemicals cancelled its analyst/investor meeting scheduled for 6 November 2026. The virtual meeting carried no financial or business event.
Tamilnad Mercantile Bank Other Announcement
Tamilnad Mercantile Bank revised its MCLR rates effective November 7, 2026. The one-year MCLR rises from 9.35% to 9.45%.
Vivid Electromech Other Announcement
Vivid Electromech filed IPO proceeds utilisation reports for the quarter ended September 30, 2026. Cumulative utilisation stood at Rs 81.64 Crore.
Molbio Diagnostics Other Announcement
Molbio Diagnostics filed CRISIL's monitoring agency report on IPO proceeds utilisation for the quarter ended 30 September 2026. The report states no deviation from the issue objects.
Bajaj Holdings & Investment Other Announcement
Bajaj Holdings & Investment filed its FY2027 Half Yearly Report for the half year ended September 2026. The report includes consolidated and standalone financial performance tables.